{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:29Z","timestamp":1787009969032,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1097\/fpc.0000000000000259","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T10:14:52Z","timestamp":1481019292000},"page":"83-88","source":"Crossref","is-referenced-by-count":31,"title":["Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia"],"prefix":"10.1097","volume":"27","author":[{"given":"Mark W.","family":"Hess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen H.F.","family":"de Baaij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.T.J.","family":"Broekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Bisseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram J.T.","family":"Haarhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan C.I.T.L.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 H.M.","family":"te Morsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost G.J.","family":"Hoenderop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 J.M.","family":"Bindels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P.H.","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210213","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3109\/0886022X.2015.1057800","article-title":"Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies","volume":"37","author":"Cheungpasitporn","year":"2015","journal-title":"Ren Fail"},{"key":"R2-1-20210213","doi-asserted-by":"crossref","first-page":"e112558","DOI":"10.1371\/journal.pone.0112558","article-title":"The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis","volume":"9","author":"Park","year":"2014","journal-title":"PLoS One"},{"key":"R3-1-20210213","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2012.05201.x","article-title":"Systematic review: hypomagnesaemia induced by proton pump inhibition","volume":"36","author":"Hess","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R4-1-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00012.2014","article-title":"Magnesium in man: implications for health and disease","volume":"95","author":"De Baaij","year":"2015","journal-title":"Physiol Rev"},{"key":"R5-1-20210213","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MOG.0b013e32833ff5d6","article-title":"Proton pump inhibitors and severe hypomagnesaemia","volume":"27","author":"Cundy","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"R6-1-20210213","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/nep.12330","article-title":"Proton-pump inhibitor use is associated with lower urinary magnesium excretion","volume":"19","author":"William","year":"2014","journal-title":"Nephrology"},{"key":"R7-1-20210213","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1074\/jbc.M311201200","article-title":"TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption","volume":"279","author":"Voets","year":"2004","journal-title":"J Biol Chem"},{"key":"R8-1-20210213","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1681\/ASN.2008030327","article-title":"EGF increases TRPM6 activity and surface expression","volume":"20","author":"Thebault","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R9-1-20210213","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.1074\/jbc.M808752200","article-title":"Regulation of the epithelial Mg2+ channel TRPM6 by estrogen and the associated repressor protein of estrogen receptor activity (REA)","volume":"284","author":"Cao","year":"2009","journal-title":"J Biol Chem"},{"key":"R10-1-20210213","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1073\/pnas.1113811109","article-title":"Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy","volume":"109","author":"Nair","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-1-20210213","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00424-014-1440-3","article-title":"P2\u00d74 receptor regulation of transient receptor potential melastatin type 6 (TRPM6) Mg2+ channels","volume":"466","author":"De Baaij","year":"2014","journal-title":"Pflugers Archiv"},{"key":"R12-1-20210213","doi-asserted-by":"crossref","first-page":"e0119028","DOI":"10.1371\/journal.pone.0119028","article-title":"Flavaglines stimulate transient receptor potential melastatin type 6 (TRPM6) channel activity","volume":"10","author":"Blanchard","year":"2015","journal-title":"PLoS One"},{"key":"R13-1-20210213","doi-asserted-by":"crossref","first-page":"25817","DOI":"10.1074\/jbc.M608972200","article-title":"Molecular determinants of Mg2+ and Ca2+ permeability and pH sensitivity in TRPM6 and TRPM7","volume":"282","author":"Li","year":"2007","journal-title":"J Biol Chem"},{"key":"R14-1-20210213","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2350-10-4","article-title":"Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women","volume":"10","author":"Song","year":"2009","journal-title":"BMC Med Genet"},{"key":"R17-1-20210213","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/genetics\/49.1.49","article-title":"The interaction of selection and linkage. I. General considerations; heterotic models","volume":"49","author":"Lewontin","year":"1964","journal-title":"Genetics"},{"key":"R18-1-20210213","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/j.ajkd.2015.05.012","article-title":"Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study","volume":"66","author":"Kieboom","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R19-1-20210213","doi-asserted-by":"crossref","first-page":"e0143656","DOI":"10.1371\/journal.pone.0143656","article-title":"Proton pump inhibitor use and magnesium concentrations in hemodialysis patients: a cross-sectional study","volume":"10","author":"Nakashima","year":"2015","journal-title":"PLoS One"},{"key":"R20-1-20210213","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cgh.2015.10.012","article-title":"Low prevalence of hypomagnesemia in long-term recipients of proton pump inhibitors in a managed care cohort","volume":"14","author":"Sharara","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-1-20210213","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1684\/mrh.2012.0325","article-title":"Hypomagnesemia in a department of internal medicine","volume":"25","author":"Liamis","year":"2012","journal-title":"Magnes Res"},{"key":"R22-1-20210213","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjmed.2012.06.037","article-title":"Electrolyte disorders in community subjects: prevalence and risk factors","volume":"126","author":"Liamis","year":"2013","journal-title":"Am J Med"},{"key":"R23-1-20210213","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ajcp\/97.6.827","article-title":"Hypomagnesemia in acute and chronic care patient populations","volume":"97","author":"Lum","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"R24-1-20210213","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jnutbio.2004.08.001","article-title":"Magnesium deficiency and osteoporosis: animal and human observations","volume":"15","author":"Rude","year":"2004","journal-title":"J Nutr Biochem"},{"key":"R25-1-20210213","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ajg.2011.113","article-title":"Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies","volume":"106","author":"Ngamruengphong","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R26-1-20210213","first-page":"515","article-title":"Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias","volume":"6","author":"El-Charabaty","year":"2013","journal-title":"Int J Gen Med"},{"key":"R27-1-20210213","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ki.2012.452","article-title":"Proton-pump inhibitor use is associated with low serum magnesium concentrations","volume":"83","author":"Danziger","year":"2013","journal-title":"Kidney Int"},{"key":"R28-1-20210213","doi-asserted-by":"crossref","first-page":"e1001736","DOI":"10.1371\/journal.pmed.1001736","article-title":"Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case\u2013control study","volume":"11","author":"Zipursky","year":"2014","journal-title":"PLoS Med"},{"key":"R29-1-20210213","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI24134","article-title":"Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia","volume":"115","author":"Nijenhuis","year":"2005","journal-title":"J Clin Invest"},{"key":"R30-1-20210213","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jash.2013.04.008","article-title":"Altered vascular structure and wave reflection in hypertensive women with low magnesium levels","volume":"7","author":"Cunha","year":"2013","journal-title":"J Am Soc Hypertens"},{"key":"R31-1-20210213","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/HYPERTENSIONAHA.113.01333","article-title":"Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study","volume":"61","author":"Joosten","year":"2013","journal-title":"Hypertension"},{"key":"R32-1-20210213","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.abb.2006.05.005","article-title":"Role of magnesium in hypertension","volume":"458","author":"Sontia","year":"2007","journal-title":"Arch Biochem Biophys"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:23:41Z","timestamp":1620937421000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201703000-00001"}},"subtitle":["a case\u2013control study"],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000259","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}